SINO BIOPHARM (01177.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow - Longbridge

Quote List Quote List

Event Tracking

Dec28

China Biologic Completes Phase II Clinical Trials for Psoriasis Drug TQH3906

22:40

Dec24

Xie Xin Increased Holdings in China Bio-Pharmaceuticals

11:25

Nomura Downgrades China Biologic Products Target Price to HKD 8.3

01:52

Dec22

Chinese Innovative Pharmaceutical Companies Discuss Overseas Strategies: From 'Riding Others' Ships' to 'Building Their Own Ships'

14:29

Dec11

Zentelxin (Cumbexil) Approved for Market by Chong Kun Dang Pharmaceutical

10:29

Dec4

ChinaBiot's Innovative Drug TQF3250 Capsules Clinical Trial Application Approved by Chinese and US Authorities

09:26

Schedules & Filings

Schedules

Filings

Sep23

Distribution Plan(CST)

Cash dividend 0.05 HKD

Sep1

Distribution Plan(CST)

Cash dividend 0.05 HKD

Aug29

Distribution Plan(CST)

Cash dividend 0.05 HKD

View More

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change

View More